advertisement
Lancet 12
Showing records 1 to 12 | Display all abstracts in Lancet80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
He M
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G; Konstantakopoulou E
Lancet 2019; 393: 1505-1516
80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
Jiang Y; Huang S
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D; Garg A
Lancet 2019; 393: 1505-1516
80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
Chang DS
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Vickerstaff V
Lancet 2019; 393: 1505-1516
80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
Munoz B; Aung T
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R; Ambler G
Lancet 2019; 393: 1505-1516
80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
Foster PJ
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Bunce C
Lancet 2019; 393: 1505-1516
80641 Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
Friedman DS
Lancet 2019; 393: 1609-1618
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Wormald R; Nathwani N; Barton K; Rubin G; Buszewicz M;
Lancet 2019; 393: 1505-1516
